INTRODUCTION
Muscarinic receptor antagonists, belladonna alkaloids in particular, have been used for a long time to treat a variety of clinical conditions, such as peptic ulcer, asthma, and Parkinson's disease (1) . Muscarinic receptor antagonists have also been used as mydriatic/cycloplegic agents (2-4) and as experimental antiperspirants (5) (6) (7) . Because of the broad range of anticholinergic effects, treatment with belladonna alkaloids directed to a certain organ system almost always induces undesirable effects in other organ systems (4) . These side effects include dry mouth, blurred vision, increased heart rate, bronchodilation, reduced bronchiolar secretions, decreased gastrointestinal motility, and reduced thermoregulatory sweating (4) . Even topical applications of anticholinergics can lead to unwanted systemic side effects because of their absorption and drainage into the systemic circulation. In a series of attempts to separate desired therapeutic effects from toxic effects⎯that is, to improve the therapeutic index⎯several series of novel anticholinergic agents have been designed, synthesized, and tested in our laboratories since the early 1980s based on soft drug design approaches (8) (9) (10) .
Soft drugs are defined as biologically active, therapeutically useful chemical compounds (drugs) characterized by a predictable and controllable in vivo destruction (metabolism) to nontoxic moieties after achieving their therapeutic role (11, 12) . Soft anticholinergics were intended for topical application, for example, to be used as antiperspirants (13) or as mydriatic agents (14, 15) . By incorporating an adequate metabolically labile moiety into their structure, they can be potent and locally active as anticholinergic agents, but with only minimal systemic anticholinergic effects due to their rapid metabolism in the systemic circulation. Thus, the overall therapeutic index is greatly improved (9, 10) .
In parallel with our efforts directed toward the development of safer anticholinergics by soft drug approaches, considerable research has been directed toward the delineation of muscarinic receptors and receptor subtypes in the past 20 years. This was done in the hope that by understanding the function of muscarinic receptors and receptor subtypes, muscarinic antagonists selectively targeted to the particular symptom(s) can be made, and, therefore, the therapeutic index can be improved (16) . Three muscarinic receptor subtypes were located and characterized by biochemical and functional studies. The M 1 receptor, which is involved in behavioral and cognitive functions, exists predominantly in the brain (17, 18) . The heart is 1 of the rare tissues where only 1 muscarinic receptor subtype, M 2 , is present (16, 19) . In secretory glands, the muscarinic receptors mediating the enhancement of secretion are of the M 3 subtype. M 3 also occurs in the smooth muscles of airways, the gastrointestinal tract, and the urinary bladder (20, 21) . With advances in molecular pharmacology in the past 15 years, 5 muscarinic receptor subtypes (m 1 , m 2 , m 3 , m 4 , and m 5 ) were cloned from human tissue (22) (23) (24) . By functional studies, the cloned receptors have proved to be well correlated with the previously established M 1 , M 2 , and M 3 receptor subtypes (25, 26) . A tissue counterpart of m 4 has been found in the peripheral lung strip of the rabbit (27, 28) ; however, the physiological function of M 4 has not been elucidated yet. The tissue and functional counterparts of m 5 have not been discovered yet.
Utilization of readily available cloned muscarinic receptor subtypes offers the possibility of studying the binding characteristics of muscarinic ligands in detail (25, 29) and, therefore, can facilitate drug discovery efforts in the search for safer anticholinergic agents. Cloned receptors have been used to determine the potency of novel compounds and to determine the subtype selectivity of antimuscarinic agents (30) (31) (32) . Currently, several muscarinic receptor subtype-selective agents are in advanced clinical trials (33, 34) .
The aims of the present study were (1) to establish and validate the method of receptor binding using cloned human muscarinic receptors as a tool for the discovery of soft anticholinergics; (2) to examine the potency and subtype selectivity of the existing and newly synthesized anticholinergics; and (3) to investigate the quantitative structureactivity relationship (QSAR) of these soft anticholinergic agents.
MATERIALS AND METHODS
Cloned m1, m2, m3, and m4 receptors were ordered from RBI (Boston, MA 
Synthesis
Ethyl tropyl-3-thienylmalonate methosulfate salt (4a) and isopropyl tropyl-3-thienylmalonate methoiodide salt (4b) (Figure 1 ). The synthesis of 4a and 4b were performed by appropriate modifications of previously reported methods (35) . Physicochemical data are listed below. 
Ethyl 3-thienylmalonic acid (2a)
m
Stability Studies of Soft Anticholinergics in the Receptor Environment
On the basis of previous studies (9, 10) , the most labile soft anticholinergics from each series of soft anticholinergics were chosen to test the integrity of the compound during incubation with the esterase enzyme inhibitor. AQC, PMTR.Et, PCMS-1, PCDT, and PCTM were chosen to test the stability in the receptor media.
Method
The incubation buffer was phosphate-buffered saline (PBS), with 10 mM NaF as esterase enzyme inhibitor. The incubation mixture (1 mL) contained 500 μL diluted receptor membrane (prepared in incubation buffer), 100 μL of 100 mM soft anticholinergic (dissolved in buffer), and 400 μL buffer. Incubation was carried out at room temperature (about 23°C) for 60 minutes. At the end of incubation, 0.1 mL of aliquots were removed, and 0.9 mL 5% DMSO in acetonitrile was added, vortexed, and centrifuged at 1000 rpm for 15 minutes. Aliquots of the supernatant (20 μL) were injected into HPLC for analysis. The HPLC system was adopted from previously reported studies (36) .
Radioligand Binding Assay
Binding studies were performed with [ 
Data Analysis
To obtain the Hill coefficients, n, data from the binding experiment were fitted to the following equation: % [ 
, where L is the concentration of the radioligand, IC 50 is the concentration of drug causing 50% inhibition of specific radioligand binding, and K D is the dissociation constant of the radioligand-receptor complex. Data were analyzed by a nonlinear least-squares curve-fitting procedure using the Scientist software (MicroMath, Salt Lake City, UT).
Guinea pig ileum assay (pA 2 value)
Standard guinea pig ileum method (35, 38) was used to determine the pA 2 values of the soft drugs. Dose response curves were plotted, and pA 2 values were calculated using a Schild plot.
Quantitative structure-activity relationship (QSAR)
All structures were optimized using the AM1 advanced semi-empirical quantum chemical method (39) Twenty-five descriptors were studied in our search for possible relevant parameters: molecular weight (MW); van der Waals molecular volume (V) and surface area ( S) together with the corresponding ovality (O) as a shape descriptor (40); effective van der Waals molecular volume ( V e ) and surface area ( S e ) together with the corresponding ovality (O e ) calculated with a new procedure and a slightly different van der Waals radii set (41); AM1 calculated dipole moment (D), average polarizability (α), ionization energy ( I), and heat of formation; HOMO-LUMO energies (E HOMO , E LUMO ); absolute electronegativity (χ), calculated as the negative of the average HOMO and LUMO energies, and absolute hardness (η), calculated as half the HOMO-LUMO difference; calculated log octanol-water partition coefficient (log P o/w ) using BLOGP (40) , QLogP (41, 42) , and MLOGP (43); calculated log water solubility (log W) using BLOGW (44); AM1-calculated partial atomic charges on the quaternary nitrogen ( q N ) atom and the sp 2 carbon and oxygen atoms of the ester moiety (q C= , q O= ); the distance between the quaternary nitrogen atom and the sp 2 carbon of the ester moiety (d C-N ); and the inaccessible solid angle around these atoms (Ω C , Ω N ) as a measure of steric hindrance (45) .
RESULTS
Stability studies showed that all tested compounds retained at least 90% integrity during the 60-minute incubation period. Table  1 presents the mean pK i ± SEM values obtained for each compound in the receptor binding studies. The pK i values obtained by us for atropine, scopolamine, p-F-HHSiD (m 3 selective agent), and pirenzepine (m 1 selective agent) were in good agreement with published data (25, 26, 29, 31) . The Hill coefficients, n, for the above compounds were not significantly different from unity, indicating that drug-receptor interactions obeyed the law of action and that binding took place at only 1 site. This further validates the method used here to evaluate the binding of the soft anticholinergi cs. However, the Hill coefficients obtained for some soft anticholinergics were significantly different from unity. Theoretically, n is an integer that reflects the number of molecules binding to a specific drug receptor. Normally, the binding of classical antagonists to muscarinic receptors is well described by the simple Langmuir isotherm, indicating a Hill coefficient close to unity (46) . Low Hill coefficients are often attributed to either recognition by the antagonist of more than 1 receptor site or conformation, or to interaction of the antagonist with a second binding site on the receptor molecule, which causes a negative cooperative effect on the first site (30, 47, 48) . None of these seems to apply in our situation. It is possible that small amounts of the inactive metabolite generated from the hydrolysis of soft drugs interfered with the binding of the parent compounds at the extremely low concentrations used in these studies (10 -4 to 10 -11 M), causing the Hill coefficients (n) to deviate from unity. In preliminary experiments, for several soft anticholinergics bound to m 3 , we observed n values below 0.8 before adding the esterase inhibitor NaF. Addition of NaF boosted the Hill coefficients to values around 0.8. Nevertheless, the exact reasons as to why n was significantly different from unity still needs further investigation. It should be pointed out that the soft anticholinergics concentrations used in the receptor binding studies were much lower than those used in the stability studies because of the HPLC detection limit. Even if the Hill coefficient (n) strongly influences the B max (maximum binding) value, it has very little effect on the estimation of IC 50 if a sigmoidal E max model is used (49) . Therefore, pK i values, which are derived from IC 50 (37) , should represent valid potency estimates even under the present experimental conditions. A validation of the receptor binding measurements on cloned muscarinic receptors is the correlation of pK i values with the pA 2 values determined by the guinea pig ileum contraction method. The correlation between pA 2 and different receptor subtype pK i are fairly good as characterized by the r 2 values (n = 18): 0.803, 0.734, 0.813, and 0.781 for m 1 , m 2 , m 3 , and m 4 , respectively. Even if differences are relatively small, the strongest correlation was observed between pA 2 and pK i (m 3 ) values (Figure 3) , which is in agreement with the fact that M 3 mediates smooth muscle in airway and gastrointestinal tract contraction (34) . Determination of the pA 2 value for guinea pig ileum contraction has been a classical functional study for anticholinergic affinity toward the M 3 receptor. For soft anticholinergics, the p A 2 values obtained from these studies were generally comparable to the pK i values obtained from m 3 binding studies, even though in most cases, the pA 2 values were somewhat lower than the corresponding p K i values of m 3 binding. Relative values for each tested compound were essentially the same for either method. Because the receptor-binding assay allows faster screening, it has an advantage over pA 2 value determination as a method to measure relative potency in anticholinergic compounds. Furthermore, the latest research indicates that muscarinic receptors in guinea pig ileum are heterogeneous with a major M 2 receptor population (~80%) and a minor M 3 population (~20%). The function of the minor M 3 population is clearly related to contraction, but the function of the predominate M 2 population is yet unclear (50) . Therefore, m 3 receptor-binding data provide a more reliable estimate of intrinsic activity toward the M 3 receptor. Twenty-four soft anticholinergic agents were included in the present study. They can be divided into 2 major groups: compounds containing at least 1 tropine moiety within their structure ( Table 2 and Table 4 ) and compounds that contain no such moiety ( Table 3 and Table 5 ). Compounds in the first group were designed by using the inactive metabolite-based soft drug approach (11, 12) . Those in the second group, except PCDT and PCTM, were designed by using the soft analogue approach (11, 12) . PMTR.Et, PMTR.cHx, and PMTR.Hx are soft analogues of atropine (35, 51) . These 3 compounds were obtained by replacing the OH groups of the methatropine moiety with different ester groups. Because atropine does not show muscarinic subtype selectivity, it is not expected that these compounds will exhibit subtype selectivity. The rank order of potency is generally m 1 ≥ m 3 >> m 2 . Studies of these 3 compounds indicated that substitution of the OH group with an ester in methatropine tends to reduce potency. This will be further discussed in the QSAR section of this paper. PMTR.MeSOMe is a similar structure containing a sulphone group, and it has moderate potency. DMPC, MPC, AQC, and MDP (Table 3 and Table 5 ) were intended for the suppression of perspiration. MDP is an analogue of propantheline and, hence, a possible anti -ulcer agent as well. All of these compounds were designed using the soft analogue approach, and they displayed higher potency in receptor-binding studies (pK i > 8.5) than most of the soft drugs designed using the inactive metabolite-based approach (pK i < 8.5). None of these compounds showed muscarinic receptor subtype selectivity. PCTM and PCDT are analogues of glycopyrrolate. Slight subtype selectivity was observed for PCTM (m 3 /m 2 binding ratio of around 8).
TMTR.Et (4a), TMTR.iPr (4b), PMTR.TR (10a), and PSTR.TR (10b) are newly synthesized soft anticholinergics. Their syntheses proceeded smoothly following appropriate modifications of previously established methodology (35) (Figure 1, Figure 2 ). TMTR.Et and TMTR.iPr are soft anticholinergics similar to PMTR.Et, PMTR.cHx, and PMTR.Hx, but with a thienyl moiety replacing the phenyl in an attempt to enhance potency. However, this replacement did not significantly increase the potency. PMTR.TR and PSTR.TR ( Figure 2 ) contain 2 tropine moieties in their structures. Binding results indicated that the increase of the number of tropine moieties did not enhance the potency either.
PCPA.Me, PCPA.Et, PCPB.Me, PCPB.Et, PCHA.Me, and PCHA.Et are soft anticholinergics with the "soft spot" (the metabolically labile moiety) introduced at the quaternary nitrogen head. Of these compounds, only PCHA.Me and PCHB.Me showed muscarinic receptor subtype selectivi ty (m 3 /m 2 ).
Quantitative structure-activity relationships (QSARs)
Because the compounds included in the study contain quaternary nitrogens and the QLogP method was not previously tested for estimation of the log distribution coefficient (log D) of such compounds, the possibility of extending this model for such predictions was evaluated. QLogP uses only 2 parameters to estimate the log octanol-water partition coefficient, log P o/w = 0.032V e -0.723N, where V e is the calculated effective van der Waals molecular volume and N is a mainly additive parameter assigned by a fully automated algorithm that has integer values and is related to hydrogen bond acceptor ability (41, 42) .
Because the distribution of charged molecules is pH-and counterion-dependent (42), experimentally determined log D values of permanently charged molecules are less reliable than experimental log partition coefficients (log P), which by definition describe the partitioning of neutral molecules. Nevertheless, as data in Table 6 indicate, the extension of QLogP could be reasonably well performed by assuming a contribution of N = 9 for the positively charged quaternary nitrogen functionality of these molecules. It is reassuring that this N = 9 value is the same as the one used earlier in the extension of the QLogP model to describe the distribution coefficient of quaternary pyridinium compounds (42) , and this can be regarded as an additional proof of the consistency of this method.
Because of the structural diversity of the compounds included in the present study, general size, shape, lipophilicity, solubility, electronic, and steric parameters were employed in the present QSAR analysis. Our initial efforts to correlate activity with physicochemical parameters for all soft anticholinergics included in this study did not prove very successful: None of the included parameters was found to be a good descriptor of the measured receptor binding data (pK i ). Size descriptors (eg, V, S, MW) proved again to be the best, but they were far less relevant than previously found for pA 2 data (9). This is true even despite the relatively good correlation found between pA 2 and pK i data (Figure 1 ). For example, V e accounts for close to 65% of the variance in pA 2 (r 2 = 0.63, n = 18), but for only about 16% of the variance in m 3 pK i (r 2 = 0.16, n = 29) (Figure 2) . Note, however, that compounds with available p K i data contain larger structural variety than those with available pA 2 data. Inclusion of second-or higher-order terms gave no significant improvement.
However, when only the soft anticholinergics with 1 or 2 tropine moiety in their structures were included, significantly improved correlation was found between activity and geometric descriptor, such as volume (V e ), surface area (S e ), and ovality (O e ). Significant correlation was also found between activity and electronic descriptor(s) such as dipole moment (D). It is not unreasonable to separate the soft anticholinergics with a tropine moiety in their structure from the other soft anticholinergics in the present study. In the compounds containing the tropine moiety, 3 carbon atoms separate the quaternary nitrogen head from the ester function. In contrast, in the compounds of Table  5 , there is a significantly shorter separation of only 1 (or sometimes 2) carbons. It is very likely that for the corresponding 2 series of soft anticholinergics, there are 2 distinct receptor-ligand complexes in terms of conformation, since the spatial structure of muscarinic receptors was considered to contain 4 binding sites (52) .
In order to establish a quantitative relationship between physicochemical parameters and activities (pK i s), the correlations between pK i (m 1 to m 3 ) and the 25 physicochemical parameters included were examined with the S-Plus program (Mathsoft, Seattle, WA). Parameters showing statistically significant correlations with the p K i values were selected, and the intercorrelations among these parameters were further examined. Of the parameters showing strong intercorrelation (r > 0.8), only 1 was kept for the final study. For example, strong intercorrelation was found among O, S, V, O e , S e , and V e ; therefore, only O e was kept for the final study as it showed the strongest correlation with the pK i values. For the final QSAR study, 8 physicochemical descriptors were selected with this procedure (Table 7) , including a geometric descriptor ( O e ), a lipophilicity descriptor (QLogP), a water-solubility descriptor (BLOGW), and 5 electronic descriptors (D, I, χ, q C= , and q O= ).
Linear regressions were obtained by using the stepwise regression mode of the S -Plus program. Following the usual methodology, only those parameters that improved (when added) or decreased (when deleted) the goodness-of-fit in a statistically significant manner were kept in the final regression model. Table 8 presents the obtained regression equations for pK i (m 1 ), pK i (m 2 ), and pK i (m 3 ), and Table 9 gives a correlation matrix between selected physicochemical descriptors and p K i values. QSAR for pK i (m 4 ) was not performed at this time because the physiological significance of m 4 has not been clearly established yet. For all 3 pK i s, O e was a major factor. Ovality, O e , is a parameter that describes the overall size and shape of the molecules (40, 41) . It is defined as the ratio between the area of the surface of the molecule and that of the minimum surface corresponding to the volume of the molecule (that is, the surface of a sphere with a volume that equals the volume of the molecule). Hence, it represents a size and shape descriptor, as it depends on the shape of the molecule and, for common organic molecules, it also scales with size. Our previous 2 structureactivity relationship studies already indicated an important role played by molecular size in this class of soft anticholinergics (9, 53) . In the present study, molecular size as measured, for example, by volume is still highly correlated with muscarinic binding activity in the analyzed 3 receptor subtypes; however, ovality (O e ) seems to be somewhat more relevant. This suggests that, in addition to size, molecular shape might also influence activity in this series of soft anticholinergics.
For For the m 3 receptor binding data, details on the stepwise improvement of the linear regression for the soft anticholinergic agents with a tropine moiety in their structure are incl uded in Table 8 . The pK i (m 3 ) were correlated in decreasing order with ovality (O e , r = 0.65), dipole moment ( D, r = 0.53), and calculated lipophilicity (QLogP, r = 0.39). Lipophilicity has been long recognized as an important factor determining antimuscarinic activity (54) (55) (56) . Because O e and D are essentially perpendicular (show very little intercorrelation: r = -0.038, Table 9 ) and both of them are well correlated with pK i (m 3 ), the combination gives a reasonably good description: pK i (m 3 Table 8 ) provides some improvement in the correlation (r = 0.88, SE = 0.39) and is statistically justified (at a p < 0.06 level), but because on the included data O e and QLogP are intercorrelated, the improvement is less significant.
DISCUSSION
It has to be mentioned again that unlike in our previous studies on guinea pig ileum pA 2 s (9,53), in this study size descriptors do not account for a majority of the variance in activity; in addition, the role of electronic properties seems to be more important. Part of the reason for this deviation might be the fact that pA 2 values are not as closely related to the contraction mediated by the M 3 receptor subtype as previously thought. The latest research indicates that muscarinic receptors in guinea pig ileum are heterogeneous with a major M 2 receptor population (~80%) and a minor M 3 population (~20%). M 3 has been clearly shown to mediate contraction, but the role M 2 plays in smooth muscle contraction is not completely clear at present. Its role might be related to the inhibition of the relaxation of the smooth muscle (33, 50) . Therefore, p K i (m 3 ) values, which are solely related to the m 3 receptor subtype, could deviate from pA 2 values, which might be related to mediation by both M 2 and M 3 receptor subtypes.
The electronic character of the molecules has already been considered as one of the most important parameters related to the antagonist activity of anticholinergic agents (54, 57, 58) . This is particularly true for the present set of molecules. The presence of a free hydroxyl group in methatropine and methscopolamine and the presence of an ester group near the tropine quaternary nitrogen head in several compounds will certainly influence the overall binding ability of the compounds to the muscarinic receptor. In an aqueous environment, the effect of electrostatic interactions may less important, but in a secluded receptor-ligand complex, the electronic effects of various substituents may easily alter the interaction of the ligand with the receptor. Many investigators have noted that esters with an OH group in the acyl side chain were generally associated with greater antimuscarinic activity. Recanatini and co-workers (59) proposed that the presence of the OH group might influence the conformation of the molecule so that t he group might interact with additional binding sites at the receptor. Other investigators related such increases to the change of the electronic properties of the overall molecule caused by the electronic withdrawing properties of the OH group (58) or to its ability to interact by electrostatic interaction or hydrogen bonding with the receptor (57). Our results seem to support the latter suggestions because electronic properties have been shown to be major factors determining antimuscarinic activity in our present QSAR study.
CONCLUSION
In conclusion, the receptor binding assay based on cloned human muscarinic receptors was proved to be a valid screening method to determine the potency of soft anticholinergic agents. Two soft anticholinergics were shown to have moderate muscarinic receptor subtype selectivity. A QSAR study performed on soft anticholinergics containing tropine moiety within their structures showed that the pK i values are related to geometric properties ( O e ), eletronic parameters (q C= , q O= , and D), and lipophilicity (QLogP).
